CART · Maplebear Inc. · Insider Trading
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-08-27 | Laughton Mary Beth |
President & CEO, Athleta |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.31 to $50.3750 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
10,236 |
| 2026-08-24 | Fong Morgan |
GENERAL COUNSEL & SECRETARY |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported stock option exercise and sales were effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on December 10, 2025. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.25 to $50.63 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
4,299 |
| 2026-08-24 | Fong Morgan |
GENERAL COUNSEL & SECRETARY |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported stock option exercise and sales were effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on December 10, 2025. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.22 to $50.18 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
14,091 |
| 2026-08-24 | Fong Morgan |
GENERAL COUNSEL & SECRETARY |
Convert↑
Filing footnotes — Common Stock (Direct)
The reported stock option exercise and sales were effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on December 10, 2025. |
Common Stock
|
18,390 |
| 2026-08-24 | Fong Morgan |
GENERAL COUNSEL & SECRETARY |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The reported stock option exercise and sales were effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on December 10, 2025. The stock option is fully vested and exercisable. |
Stock Option (Right to Buy)
|
18,390 |
| 2026-08-19 | Gupta Ravi |
Director, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Indirect)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.14 to $50.77. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, the full information regarding the number of shares sold at each separate price within the ranges set forth above. |
Common Stock
(I)
|
150,000 |
| 2026-08-19 | Rogers Chris |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported sales were effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on November 20, 2025. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.67 to $49.2350 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
7,606 |
| 2026-08-15 | Rogers Chris |
Director, President and CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units. |
Common Stock
|
43,807 |
| 2026-08-15 | BLACKWOOD-KAPRAL LISA |
CHIEF ACCOUNTING OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units. |
Common Stock
|
6,103 |
| 2026-08-15 | Fong Morgan |
GENERAL COUNSEL & SECRETARY |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units. |
Common Stock
|
14,167 |
| 2026-08-15 | Reuter Emily |
CHIEF FINANCIAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units. |
Common Stock
|
19,188 |
| 2026-08-13 | Reuter Emily |
CHIEF FINANCIAL OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported sales were effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on May 8, 2026. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.08 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
25,000 |
| 2026-08-10 | SC US (TTGP), LTD. |
10% Owner |
Other↓
Filing footnotes — Common Stock (Indirect)
Represents a pro rata in-kind distribution of shares of Common Stock of the Issuer to partners or members for no consideration and includes subsequent pro rata in-kind distributions by general partners or managing members to their respective partners or members for no consideration. SC US (TTGP), Ltd. is (i) the general partner of SCGGF III - Endurance Partners Management, L.P., which is the general partner of Sequoia Capital Global Growth Fund III - Endurance Partners, L.P., or GGF III; (ii) the general partner of SCGGF III - U.S./India Management, L.P., or GGF III US IND MGMT; (iii) the general partner of SC US/E Expansion Fund I Management, L.P., which is the general partner of Sequoia Capital US/E Expansion Fund I, L.P., collectively, the EXP I Funds; (iv) the general partner of Sequoia Capital Fund Management, L.P., which is the general partner of Sequoia Capital Fund, LP, or SCF and the managing member of Sequoia Capital Fund Parallel, LLC, or SCFP, collectively, the SCF Funds. (Continue from Footnote 2) As a result, SC US (TTGP), Ltd. may be deemed to share voting and dispositive power with respect to the shares held by GGF III, GGFIII US IND MGMT, the EXP I Funds and the SCF Funds. Each of such reporting persons disclaims beneficial ownership of the shares held by GGF III, GGFIII US IND MGMT, the EXP I Funds and the SCF Funds except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. |
Common Stock
(I)
|
924,221 |
| 2026-08-10 | SC US (TTGP), LTD. |
10% Owner |
Other↓
Filing footnotes — Common Stock (Indirect)
Represents a pro rata in-kind distribution of shares of Common Stock of the Issuer to partners or members for no consideration and includes subsequent pro rata in-kind distributions by general partners or managing members to their respective partners or members for no consideration. SC US (TTGP), Ltd. is (i) the general partner of SCGGF III - Endurance Partners Management, L.P., which is the general partner of Sequoia Capital Global Growth Fund III - Endurance Partners, L.P., or GGF III; (ii) the general partner of SCGGF III - U.S./India Management, L.P., or GGF III US IND MGMT; (iii) the general partner of SC US/E Expansion Fund I Management, L.P., which is the general partner of Sequoia Capital US/E Expansion Fund I, L.P., collectively, the EXP I Funds; (iv) the general partner of Sequoia Capital Fund Management, L.P., which is the general partner of Sequoia Capital Fund, LP, or SCF and the managing member of Sequoia Capital Fund Parallel, LLC, or SCFP, collectively, the SCF Funds. (Continue from Footnote 2) As a result, SC US (TTGP), Ltd. may be deemed to share voting and dispositive power with respect to the shares held by GGF III, GGFIII US IND MGMT, the EXP I Funds and the SCF Funds. Each of such reporting persons disclaims beneficial ownership of the shares held by GGF III, GGFIII US IND MGMT, the EXP I Funds and the SCF Funds except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. |
Common Stock
(I)
|
924,221 |
| 2026-08-10 | SC US (TTGP), LTD. |
10% Owner |
Other↓
Filing footnotes — Common Stock (Indirect)
Represents a pro rata in-kind distribution of shares of Common Stock of the Issuer to partners or members for no consideration and includes subsequent pro rata in-kind distributions by general partners or managing members to their respective partners or members for no consideration. SC US (TTGP), Ltd. is (i) the general partner of SCGGF III - Endurance Partners Management, L.P., which is the general partner of Sequoia Capital Global Growth Fund III - Endurance Partners, L.P., or GGF III; (ii) the general partner of SCGGF III - U.S./India Management, L.P., or GGF III US IND MGMT; (iii) the general partner of SC US/E Expansion Fund I Management, L.P., which is the general partner of Sequoia Capital US/E Expansion Fund I, L.P., collectively, the EXP I Funds; (iv) the general partner of Sequoia Capital Fund Management, L.P., which is the general partner of Sequoia Capital Fund, LP, or SCF and the managing member of Sequoia Capital Fund Parallel, LLC, or SCFP, collectively, the SCF Funds. (Continue from Footnote 2) As a result, SC US (TTGP), Ltd. may be deemed to share voting and dispositive power with respect to the shares held by GGF III, GGFIII US IND MGMT, the EXP I Funds and the SCF Funds. Each of such reporting persons disclaims beneficial ownership of the shares held by GGF III, GGFIII US IND MGMT, the EXP I Funds and the SCF Funds except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. |
Common Stock
(I)
|
5,203,747 |
| 2026-08-10 | SC US (TTGP), LTD. |
10% Owner |
Other↓
Filing footnotes — Common Stock (Indirect)
Represents a pro rata in-kind distribution of shares of Common Stock of the Issuer to partners or members for no consideration and includes subsequent pro rata in-kind distributions by general partners or managing members to their respective partners or members for no consideration. SC US (TTGP), Ltd. is (i) the general partner of SCGGF III - Endurance Partners Management, L.P., which is the general partner of Sequoia Capital Global Growth Fund III - Endurance Partners, L.P., or GGF III; (ii) the general partner of SCGGF III - U.S./India Management, L.P., or GGF III US IND MGMT; (iii) the general partner of SC US/E Expansion Fund I Management, L.P., which is the general partner of Sequoia Capital US/E Expansion Fund I, L.P., collectively, the EXP I Funds; (iv) the general partner of Sequoia Capital Fund Management, L.P., which is the general partner of Sequoia Capital Fund, LP, or SCF and the managing member of Sequoia Capital Fund Parallel, LLC, or SCFP, collectively, the SCF Funds. (Continue from Footnote 2) As a result, SC US (TTGP), Ltd. may be deemed to share voting and dispositive power with respect to the shares held by GGF III, GGFIII US IND MGMT, the EXP I Funds and the SCF Funds. Each of such reporting persons disclaims beneficial ownership of the shares held by GGF III, GGFIII US IND MGMT, the EXP I Funds and the SCF Funds except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. |
Common Stock
(I)
|
5,203,747 |
| 2026-08-07 | Rogers Chris |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported sales were effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on November 20, 2025. |
Common Stock
|
4,933 |
| 2026-07-22 | Fong Morgan |
GENERAL COUNSEL & SECRETARY |
Convert↑
Filing footnotes — Common Stock (Direct)
The reported stock option exercise and sales were effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on December 10, 2025. |
Common Stock
|
18,390 |
| 2026-07-22 | Fong Morgan |
GENERAL COUNSEL & SECRETARY |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The reported stock option exercise and sales were effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on December 10, 2025. The stock option is fully vested and exercisable. |
Stock Option (Right to Buy)
|
18,390 |
| 2026-07-22 | Fong Morgan |
GENERAL COUNSEL & SECRETARY |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported stock option exercise and sales were effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on December 10, 2025. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.90 to $44.73 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
18,390 |
| 2026-07-15 | BLACKWOOD-KAPRAL LISA |
CHIEF ACCOUNTING OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported sales were effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on November 20, 2025. |
Common Stock
|
3,016 |
| 2026-06-15 | BLACKWOOD-KAPRAL LISA |
CHIEF ACCOUNTING OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported sales were effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on November 20, 2025. |
Common Stock
|
3,017 |
| 2026-06-02 | Gupta Ravi |
Director, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Indirect)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.01 to $41.90. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, the full information regarding the number of shares sold at each separate price within the ranges set forth above. |
Common Stock
(I)
|
181,000 |
| 2026-06-01 | Rogers Chris |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported sales were effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on November 20, 2025. |
Common Stock
|
7,893 |
| 2026-05-22 | Gupta Ravi |
Director, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
The shares represent restricted stock units, which vest in full on the earlier of (i) the date of the Issuer's next annual meeting of stockholders (or the date immediately prior to such meeting if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election) or (ii) the one-year anniversary of the grant date, in each case subject to the Reporting Person's continued service through such date. |
Common Stock
|
6,048 |
| 2026-05-22 | Laughton Mary Beth |
President & CEO, Athleta |
Award↑
Filing footnotes — Common Stock (Direct)
The shares represent restricted stock units, which vest in full on the earlier of (i) the date of the Issuer's next annual meeting of stockholders (or the date immediately prior to such meeting if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election) or (ii) the one-year anniversary of the grant date, in each case subject to the Reporting Person's continued service through such date. |
Common Stock
|
6,048 |
| 2026-05-22 | Sarafan Lily |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares represent restricted stock units, which vest in full on the earlier of (i) the date of the Issuer's next annual meeting of stockholders (or the date immediately prior to such meeting if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election) or (ii) the one-year anniversary of the grant date, in each case subject to the Reporting Person's continued service through such date. |
Common Stock
|
6,048 |
| 2026-05-22 | KOPIT LEVIEN MEREDITH A. |
Director, PRESIDENT & CEO |
Award↑
Filing footnotes — Common Stock (Direct)
The shares represent restricted stock units, which vest in full on the earlier of (i) the date of the Issuer's next annual meeting of stockholders (or the date immediately prior to such meeting if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election) or (ii) the one-year anniversary of the grant date, in each case subject to the Reporting Person's continued service through such date. |
Common Stock
|
6,048 |
| 2026-05-22 | Sundheim Daniel S. |
Director, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
The shares represent restricted stock units received by Daniel Sundheim ("Mr. Sundheim"), which vest in full on the earlier of (i) the date of the Issuer's next annual meeting of stockholders (or the date immediately prior to such meeting if Mr. Sundheim's service as a director ends at such meeting due to Mr. Sundheim's failure to be re-elected or Mr. Sundheim not standing for re-election) or (ii) the one-year anniversary of the grant date, in each case subject to Mr. Sundheim's continued service through such date. Represents securities held by Mr. Sundheim. Mr. Sundheim may be deemed to hold the securities reported herein for the benefit of certain funds and accounts to which the Investment Manager (as defined below) serves as the investment manager or investment consultant. This statement is filed by D1 Capital Partners L.P. (the "Investment Manager") and Mr. Sundheim. The foregoing persons are hereinafter sometimes referred to as the "Reporting Persons." The filing of this statement should not be construed as an admission that any Reporting Person is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of the securities reported except to the extent of its pecuniary interest therein, if any. |
Common Stock
|
6,048 |
| 2026-05-22 | Dolan Victoria L |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares represent restricted stock units, which vest in full on the earlier of (i) the date of the Issuer's next annual meeting of stockholders (or the date immediately prior to such meeting if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election) or (ii) the one-year anniversary of the grant date, in each case subject to the Reporting Person's continued service through such date. |
Common Stock
|
6,048 |
| 2026-05-22 | Silverman Josh |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares represent restricted stock units, which vest in full on the earlier of (i) the date of the Issuer's next annual meeting of stockholders (or the date immediately prior to such meeting if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election) or (ii) the one-year anniversary of the grant date, in each case subject to the Reporting Person's continued service through such date. |
Common Stock
|
6,048 |
| 2026-05-18 | Fong Morgan |
GENERAL COUNSEL & SECRETARY |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported sales were effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on December 10, 2025. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.34 to $40.47 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
1,458 |
| 2026-05-18 | Fong Morgan |
GENERAL COUNSEL & SECRETARY |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported sales were effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on December 10, 2025. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.34 to $40.3150 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
12,575 |
| 2026-05-15 | BLACKWOOD-KAPRAL LISA |
CHIEF ACCOUNTING OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units. |
Common Stock
|
6,103 |
| 2026-05-15 | Reuter Emily |
CHIEF FINANCIAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units. |
Common Stock
|
26,929 |
| 2026-05-15 | Rogers Chris |
Director, President and CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units. |
Common Stock
|
45,464 |
| 2026-05-15 | Fong Morgan |
GENERAL COUNSEL & SECRETARY |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units. |
Common Stock
|
15,898 |
| 2026-04-15 | BLACKWOOD-KAPRAL LISA |
CHIEF ACCOUNTING OFFICER |
Award↑
Filing footnotes — Common Stock (Direct)
The shares represent restricted stock units (RSUs). 12.5% of the RSUs vest on the first quarterly anniversary of February 15, 2026, and the remainder of the RSUs vest in 7 equal quarterly installments thereafter, subject to continued service through each vesting date. |
Common Stock
|
20,851 |
| 2026-04-15 | Fong Morgan |
GENERAL COUNSEL & SECRETARY |
Award↑
Filing footnotes — Common Stock (Direct)
The shares represent restricted stock units (RSUs). Twenty percent (20%) of the RSUs vest on each quarterly anniversary of November 15, 2027, subject to continued service through each vesting date. |
Common Stock
|
187,366 |
| 2026-04-15 | BLACKWOOD-KAPRAL LISA |
CHIEF ACCOUNTING OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported sales were effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on November 20, 2025. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.53 to $40.50 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
9,390 |
| 2026-04-15 | Reuter Emily |
CHIEF FINANCIAL OFFICER |
Award↑
Filing footnotes — Common Stock (Direct)
The shares represent restricted stock units (RSUs). Twenty percent (20%) of the RSUs vest on each quarterly anniversary of November 15, 2027, subject to continued service through each vesting date. |
Common Stock
|
254,283 |
| 2026-04-15 | Rogers Chris |
Director, President and CEO |
Award↑
Filing footnotes — Common Stock (Direct)
The shares represent restricted stock units (RSUs). Twenty percent (20%) of the RSUs vest on each quarterly anniversary of November 15, 2027, subject to continued service through each vesting date. |
Common Stock
|
376,405 |
| 2026-03-16 | BLACKWOOD-KAPRAL LISA |
CHIEF ACCOUNTING OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported sales were effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on November 20, 2025. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.1225 to $39.04 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
9,390 |
| 2026-03-11 | Fong Morgan |
GENERAL COUNSEL & SECRETARY |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported stock option exercise and sales were effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on December 10, 2025. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.23 to $37.22 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
75,219 |
| 2026-03-11 | Fong Morgan |
GENERAL COUNSEL & SECRETARY |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported stock option exercise and sales were effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on December 10, 2025. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.23 to $37.97 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
35,121 |
| 2026-03-11 | Fong Morgan |
GENERAL COUNSEL & SECRETARY |
Convert↑
Filing footnotes — Common Stock (Direct)
The reported stock option exercise and sales were effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on December 10, 2025. |
Common Stock
|
110,340 |
| 2026-03-11 | Fong Morgan |
GENERAL COUNSEL & SECRETARY |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported sales were effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on December 10, 2025. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.26 to $37.98 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
4,955 |
| 2026-03-11 | Fong Morgan |
GENERAL COUNSEL & SECRETARY |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported sales were effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on December 10, 2025. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.25 to $37.24 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
10,788 |
| 2026-03-11 | Fong Morgan |
GENERAL COUNSEL & SECRETARY |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The reported stock option exercise and sales were effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on December 10, 2025. The stock option is fully vested and exercisable. |
Stock Option (Right to Buy)
|
110,340 |
| 2026-02-25 | Sarafan Lily |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.5201 to $36.53 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
3,500 |